EG18982A
(en )
1995-01-31
Leather treatment with selected amphiphilic copolymers
GB2221390B
(en )
1992-02-05
Niacin-containing composition and its therapeutic use
EP0330496A3
(en )
1990-02-28
Skin treatment composition
ZA893291B
(en )
1990-01-31
Hard tissue surface treatment
ZA899066B
(en )
1991-07-31
Fabric treatment composition
EP0437026A3
(en )
1991-10-02
Use of tandospirone in the treatment of depression
GB2203645B
(en )
1990-10-24
Improvements in the treatment of hair
GB8815634D0
(en )
1988-08-03
Hair treatment
GB8804531D0
(en )
1988-03-30
Skin treatment formulations
GB2228489B
(en )
1992-06-10
Surface treatment
GB8908742D0
(en )
1989-06-07
Water treatment
GB8802745D0
(en )
1988-03-09
Leather treatment
SG142794G
(en )
1995-04-28
The use of selected amphiphilic copolymers in the treatment of leather
ZA899065B
(en )
1991-07-31
Fabric treatment composition
ZA893261B
(en )
1991-01-30
Synergistic combinations and their use as therapeutic agents
SG47098A1
(en )
1998-03-20
Diamines in the treatment of arrhythmia
GB8908549D0
(en )
1989-06-01
Liquid leather treatment composition
GB8814940D0
(en )
1988-07-27
Leather treatment
GB8804420D0
(en )
1988-03-23
Skin treatment composition
GB8819737D0
(en )
1988-09-21
Skin treatment composition
PH25733A
(en )
1991-10-18
5-aryl-3h-1,2,4-triazol-3-ones, their use in the treatment of neurogenerative disorders
IL94270A0
(en )
1991-03-10
Anti-ergotypic t cells for the treatment or prevention of autoimmune diseases and methods of use thereof
SG4695G
(en )
1995-06-16
Use of 2-oxo-imidazolidine derivatives in the treatment of kidney-diseases
IL92015A0
(en )
1990-07-12
Tissue plasminogen activator muteins and processes for the preparation thereof
GB8809266D0
(en )
1988-05-25
Treatment